As planned, US drugmaker Pfizer and German biotech BioNTech filed an Emergency Use Authorization (EUA) request with the US Food and Drug Administration (FDA) for their...

The biotech industry in Italy is vital and is showing a constant growth, report by Assobiotec and ENEA documents.

German biotech CureVac has signed a supply agreement with the European Commission to provide an initial 225 million doses of its mRNA-based Covid-19 vaccine, with an...

UK specialty chemical company Croda International has agreed to supply Pfizer with novel excipients used to make the drugmaker’s Covid-19 vaccine candidate. The contract...

Results from the Phase 3 trial of US biotech Moderna’s mRNA-1273 Covid-19 vaccine candidate unveiled on Nov. 15 showed it to be 94.5% effective against the novel...

Phase 3 clinical trials with the mRNA vaccine candidate BNT162b2 being developed by US pharma giant Pfizer and German biotech partner BioNTech have shown it to be more...

US vaccine manufacturer Moderna has tapped Takeda as marketing partner for its Covid-19 vaccine candidate mRNA-1273f in Japan. Financial terms of the deal were not...

On November 1, 2020, Sean Diver took the reins as President of the Drug, Chemical & Associated Technologies Association (DCAT).

French pharma Sanofi is boosting once again its immunology portfolio with an agreement to buy Dutch biotech Kiadis for €308 million.

French and British drugmakers Sanofi and GlaxoSmithKline (GSK) have signed on with Gavi, the global vaccine alliance, to make 200 million doses of their experimental...